Suzuki H, Miyazaki M, Iinuma K, Udagawa I, Koshikawa H, Ito H, Okui K
First Department of Surgery, Chiba University, School of Medicine, Japan.
Nihon Geka Gakkai Zasshi. 1991 Oct;92(10):1480-5.
We studied selective accumulation and retention of lipiodol (LP) and anticancer agents in normal and regenerating liver tissue following portal infusion in rats. Total concentration of Aclarubicin (ACR) and its metabolites in liver tissue was higher in ACR + LP portal infusion group than in ACR portal infusion group both in normal and regenerating liver, concentration of active metabolites of ACR was higher in ACR portal infusion group than in ACR peripheral infusion group. Much higher concentration was found in ACR + LP portal infusion group. Histologic examination revealed more toxic effect on regenerating liver in ACR portal infusion group than in ACR + LP portal infusion group. Oil red staining demonstrated the retention of lipiodol more than 7 days following intraportal infusion in regenerating liver tissue. This study confirms that the ACR + LP portal infusion induces selective accumulation and long-term retention in normal and regenerating liver tissue, and may enhance the antitumor effect of drugs.
我们研究了大鼠门静脉注射后,正常肝组织和再生肝组织中碘油(LP)及抗癌药物的选择性蓄积和滞留情况。在正常肝组织和再生肝组织中,阿柔比星(ACR)+LP门静脉注射组肝组织中阿柔比星及其代谢产物的总浓度均高于ACR门静脉注射组,ACR门静脉注射组中ACR活性代谢产物的浓度高于ACR外周注射组。ACR+LP门静脉注射组中的浓度更高。组织学检查显示,ACR门静脉注射组对再生肝的毒性作用大于ACR+LP门静脉注射组。油红染色显示门静脉注射后,碘油在再生肝组织中滞留超过7天。本研究证实,ACR+LP门静脉注射可诱导在正常肝组织和再生肝组织中选择性蓄积和长期滞留,并可能增强药物的抗肿瘤作用。